SCHEMBL21394815

SCHEMBL21394815

Cc1cc(NC(=O)OC(C)(C)C)ncc1Cc1cccc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.49
CYP2C9 P11712 1/20 0.49
CDK9 P50750 1/20 0.45
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
CTSL P07711 1/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPK1 P28482 1/20 0.40
S1PR3 Q99500 1/20 0.39
CDK1 P06493 1/20 0.39
LCK P06239 2/20 0.39
DYRK1A Q13627 2/20 0.39
GSK3B P49841 1/20 0.39
EGFR P00533 1/20 0.39
SRC P12931 1/20 0.39
KLKB1 P03952 1/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
ALDH1A1 P00352 1/20 0.38
CCR2 P41597 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29353829 1.00 PTGER1 (0.49) PTGER1CYP2C9CDK9MAPTLMNA
SCHEMBL21384164 0.85 MAPT (0.48) CYP2C9MAPTLMNAKDM4EMAPK1
SCHEMBL21394568 0.82 CCR2 (0.50) PTGER1CYP2C9LMNACTSLKDM4E
SCHEMBL29442824 0.82 CCR2 (0.50) PTGER1CYP2C9LMNACTSLKDM4E
SCHEMBL29358615 0.82 CCR2 (0.50) PTGER1CYP2C9LMNACTSLKDM4E
SCHEMBL21394859 0.77 KDM4E (0.46) PTGER1CYP2C9CTSLKDM4E
SCHEMBL29353767 0.77 KDM4E (0.46) PTGER1CYP2C9CTSLKDM4E
SCHEMBL7257381 0.77 GSK3B (0.43) PTGER1CYP2C9CDK9MAPK1LCK
Hydrochloric Acid SCHEMBL7410594 0.76 GSK3B (0.42) PTGER1CYP2C9CDK9MAPK1LCK
SCHEMBL12225872 0.73 GSK3B (0.48) PTGER1MAPK1LCKDYRK1AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198026-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed